Sandra Petrus-Reurer1, Hammurabi Bartuma2, Monica Aronsson2, Sofie Westman2, Fredrik Lanner3, Helder André2, Anders Kvanta2. 1. Department of Clinical Neuroscience, Section for Ophthalmology and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden 2Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden and Division of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden. 2. Department of Clinical Neuroscience, Section for Ophthalmology and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. 3. Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden and Division of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden.
Abstract
Purpose: Subretinal suspension transplants of human embryonic stem cell-derived retinal pigment epithelial cells (hESC-RPE) have the capacity to form functional monolayers in naive eyes. We explore hESC-RPE integration when transplanted in suspension to a large-eyed model of geographic atrophy (GA). Methods: Derivation of hESC-RPE was performed in a xeno-free and defined manner. Subretinal bleb injection of PBS or sodium iodate (NaIO3) was used to induce a GA-like phenotype. Suspensions of hESC-RPE were transplanted to the subretinal space of naive or PBS-/NaIO3-treated rabbits using a transvitreal pars plana technique. Integration of hESC-RPE was monitored by multimodal real-time imaging and by immunohistochemistry. Results: Subretinal blebs of PBS or NaIO3 caused different degrees of outer neuroretinal degeneration, RPE hyperautofluorescence, focal RPE loss, and choroidal atrophy; that is, hallmark characteristics of GA. In nonpretreated naive eyes, hESC-RPE integrated as subretinal monolayers with preserved overlying photoreceptors, yet not in areas with outer neuroretinal degeneration and native RPE loss. When transplanted to eyes with PBS-/NaIO3-induced degeneration, hESC-RPE failed to integrate. Conclusions: In a large-eyed preclinical model, subretinal suspension transplants of hESC-RPE did not integrate in areas with GA-like degeneration.
Purpose: Subretinal suspension transplants of human embryonic stem cell-derived retinal pigment epithelial cells (hESC-RPE) have the capacity to form functional monolayers in naive eyes. We explore hESC-RPE integration when transplanted in suspension to a large-eyed model of geographic atrophy (GA). Methods: Derivation of hESC-RPE was performed in a xeno-free and defined manner. Subretinal bleb injection of PBS or sodium iodate (NaIO3) was used to induce a GA-like phenotype. Suspensions of hESC-RPE were transplanted to the subretinal space of naive or PBS-/NaIO3-treated rabbits using a transvitreal pars plana technique. Integration of hESC-RPE was monitored by multimodal real-time imaging and by immunohistochemistry. Results:Subretinal blebs of PBS or NaIO3 caused different degrees of outer neuroretinal degeneration, RPE hyperautofluorescence, focal RPE loss, and choroidal atrophy; that is, hallmark characteristics of GA. In nonpretreated naive eyes, hESC-RPE integrated as subretinal monolayers with preserved overlying photoreceptors, yet not in areas with outer neuroretinal degeneration and native RPE loss. When transplanted to eyes with PBS-/NaIO3-induced degeneration, hESC-RPE failed to integrate. Conclusions: In a large-eyed preclinical model, subretinal suspension transplants of hESC-RPE did not integrate in areas with GA-like degeneration.
Authors: Tai-Chi Lin; Magdalene J Seiler; Danhong Zhu; Paulo Falabella; David R Hinton; Dennis O Clegg; Mark S Humayun; Biju B Thomas Journal: Stem Cells Int Date: 2017-08-27 Impact factor: 5.443
Authors: Brittni A Scruggs; Chunhua Jiao; Cathryn M Cranston; Emily Kaalberg; Kai Wang; Stephen R Russell; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker; Elliott H Sohn Journal: Stem Cells Transl Med Date: 2019-04-19 Impact factor: 6.940
Authors: Imran A Bhutto; Shuntaro Ogura; Rajkumar Baldeosingh; D Scott McLeod; Gerard A Lutty; Malia M Edwards Journal: Invest Ophthalmol Vis Sci Date: 2018-03-20 Impact factor: 4.799